A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MS / mood stabilizer

[Related PubMed/MEDLINE]
Total Number of Papers: 39
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MS  (>> Co-occurring Abbreviation)
Long Form:   mood stabilizer
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia. AD
2019 Clinical characteristics of antidepressant use and related manic switch in bipolar disorder. AD, AD-c, AD-m, BD
2019 Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines. AAP, KMAP-BP 2018
2019 Reversibility of psychotropic medication induced weight gain among children and adolescents with bipolar disorders. SGA
2019 [Psychiatric polypharmacy and electroconvulsive therapy in treatment-resistant depression]. AP, BZD, ECT, ECT, mod-DBI, TRD
2018 Associations between use of mood stabilizers and risk of cataract: A population-based nested case-control study. AOR, BD
2018 Challenging the Negative Perception of Lithium and Optimizing Its Long-Term Administration. ER
2018 Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision. AAP, KMAP-BP, KMAP-BP 2018, LMT
2018 The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland. BP, CGI-I, SGA
10  2017 Clinical Use of Mood Stabilizers With Antidepressants in Asia: Report From the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD) Projects in 2004 and 2013. AD, REAP-AD
11  2017 Effect of Psychopharmacotherapy on Body Mass Index Among Children and Adolescents with Bipolar Disorders. AD, AT, BMI
12  2016 Current prescription pattern of maintenance treatments for bipolar patients in Korea: A focus on the transition from acute treatments. AD
13  2015 Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes. SGAP, STEP-BD
14  2015 Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines. AAP, KMAP-BP 2014
15  2015 Korean Medication Algorithm Project for Bipolar Disorder: third revision. AAP, LTG, TOC
16  2015 Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis. AEs, AP, BD
17  2014 Can the response to mood stabilizers be predicted in bipolar disorder? BD
18  2014 Comparative effectiveness of monotherapy with mood stabilizers versus second generation (atypical) antipsychotics for the treatment of bipolar disorder in children and adolescents. PBD
19  2014 Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011. BD, SGA, STEP-BD
20  2013 Korean medication algorithm for bipolar disorder: second revision. AAP, AD, KMAP-BP 2002
21  2013 Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. AP, CI
22  2012 Adjunctive mood stabilizer and benzodiazepine use in older Asian patients with schizophrenia, 2001-2009. BZD, EPS, REAP
23  2011 Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis. SGA, SMD
24  2011 Long-term worsening of bipolar disorder related with frequency of antidepressant exposure. AD, BD
25  2011 When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations. ---
26  2010 Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. CI, DB-RPCT, ES, SGAs
27  2010 Healthcare costs of atypical antipsychotic use for patients with bipolar disorder in a Medicaid programme. ---
28  2009 Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation. ---
29  2009 Revised Korean medication algorithm for bipolar disorder. AAP, AD, KMAP-BP
30  2008 Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. AD, BP-II, MDE, YMRS
31  2008 Hospital use of antipsychotic drugs: polytherapy. ---
32  2008 Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. AD, BPD, NNH, NNT
33  2007 Atypical antipsychotics as "mood stabilizers": a retrospective chart review. AA, BRMRS, CGI, HAMD
34  2007 Atypical antipsychotics related metabolic syndrome in bipolar patients. AA, MetS
35  2005 Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study. MDE
36  2005 Newer treatment studies for bipolar depression. OFC
37  2005 Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study. BMI, CGI, DVPG, EPS, SARS, TPMG, YMRS
38  2004 The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program. BP, non-BP, recognized-BP, unrecognized-BP
39  2002 Previous mood state predicts response and switch rates in patients with bipolar depression. AD